Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
469 GBX | +3.17% | +5.82% | -3.70% |
07/05 | AstraZeneca target raised; Antofagasta lowered | AN |
19/04 | Peel Hunt starts NatWest and Barclays at 'buy' | AN |
Sales 2024 * | 1.84B 2.3B 192B | Sales 2025 * | 1.98B 2.48B 207B | Capitalization | 1.47B 1.84B 154B |
---|---|---|---|---|---|
Net income 2024 * | 64M 80.11M 6.69B | Net income 2025 * | 91M 114M 9.51B | EV / Sales 2024 * | 0.8 x |
Net cash position 2024 * | 8.12M 10.16M 849M | Net cash position 2025 * | 13.65M 17.09M 1.43B | EV / Sales 2025 * | 0.74 x |
P/E ratio 2024 * |
23
x | P/E ratio 2025 * |
15.7
x | Employees | 7,859 |
Yield 2024 * |
5.11% | Yield 2025 * |
6.07% | Free-Float | 94.58% |
Latest transcript on PageGroup plc
1 day | +3.17% | ||
1 week | +5.82% | ||
Current month | +5.11% | ||
1 month | -4.44% | ||
3 months | +4.59% | ||
6 months | +12.58% | ||
Current year | -3.70% |
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Kirk
CEO | Chief Executive Officer | - | 01/23/01 |
Director of Finance/CFO | 52 | 01/06/01 | |
Kaye Maguire
LAW | General Counsel | - | 17/18/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marie Metayer
BRD | Director/Board Member | 64 | 01/17/01 |
Director of Finance/CFO | 52 | 01/06/01 | |
Karen Geary
BRD | Director/Board Member | - | 01/22/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
10/24/10 | 469 | +3.17% | 357,140 |
09/24/09 | 454.6 | +2.85% | 524,706 |
08/24/08 | 442 | -1.07% | 333,857 |
07/24/07 | 446.8 | +0.81% | 275,536 |
03/24/03 | 443.2 | -0.27% | 157,358 |
Delayed Quote London S.E., May 10, 2024 at 09:05 pm IST
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.70% | 1.84B | |
+8.71% | 3.37B | |
-8.33% | 1.99B | |
+12.50% | 673M |
- Stock Market
- Equities
- MPI Stock